Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Financial and clinical impact of team-based treatment for medicaid enrollees with diabetes in a federally qualified health center.

    Scanlon DP, Hollenbeak CS, Beich J, Dyer AM, Gabbay RA, Milstein A.

    Diabetes Care. 2008 Nov;31(11):2160-5. Epub 2008 Aug 4.PMID: 18678609 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk.

    Kirsh S, Watts S, Pascuzzi K, O'Day ME, Davidson D, Strauss G, Kern EO, Aron DC.

    Qual Saf Health Care. 2007 Oct;16(5):349-53.PMID: 17913775 [PubMed - indexed for MEDLINE]Related articles

    3.

    Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

    Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

    J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.

    Trygstad TK, Christensen D, Garmise J, Sullivan R, Wegner S.

    J Manag Care Pharm. 2005 Sep;11(7):575-83.PMID: 16137215 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Systemwide provider performance in a Medicaid program. Profiling the care of patients with chronic illnesses.

    Powe NR, Weiner JP, Starfield B, Stuart M, Baker A, Steinwachs DM.

    Med Care. 1996 Aug;34(8):798-810.PMID: 8709661 [PubMed - indexed for MEDLINE]Related articles

    7.

    Improvements in diabetes management and outcomes in a Medicaid managed care system.

    Bailey JE, Womeodu RJ, Wan JY, Van Brunt DL, Somes GW.

    Tenn Med. 2001 Nov;94(11):425-30.PMID: 11709896 [PubMed - indexed for MEDLINE]Related articles

    8.

    Medicaid managed care: are academic medical centers penalized by attracting patients with high-cost conditions?

    Heisler M, DeMonner SM, Billi JE, Hayward RA.

    Am J Manag Care. 2003 Jan;9(1):19-29.PMID: 12549812 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.

    Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.

    J Manag Care Pharm. 2007 May;13(4):349-59.PMID: 17506601 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.

    Fox D, Ried LD, Klein GE, Myers W, Foli K.

    J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):192-9.PMID: 19289345 [PubMed - indexed for MEDLINE]Related articles

    12.

    Challenges in merging Medicaid and Medicare databases to obtain healthcare costs for dual-eligible beneficiaries: using diabetes as an example.

    Prela CM, Baumgardner GA, Reiber GE, McFarland LV, Maynard C, Anderson N, Maciejewski M.

    Pharmacoeconomics. 2009;27(2):167-77. doi: 10.2165/00019053-200927020-00007.PMID: 19254049 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetes Ten City Challenge: final economic and clinical results.

    Fera T, Bluml BM, Ellis WM.

    J Am Pharm Assoc (2003). 2009 May-Jun;49(3):383-91.PMID: 19357068 [PubMed - indexed for MEDLINE]Related articles

    14.

    Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

    Plosker GL, Figgitt DP.

    Pharmacoeconomics. 2004;22(6):389-411. Review.PMID: 15099124 [PubMed - indexed for MEDLINE]Related articles

    15.

    Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: results of a controlled trial.

    Maddigan SL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

    Diabetes Care. 2004 Jun;27(6):1306-12.PMID: 15161780 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The Informatics for Diabetes and Education Telemedicine (IDEATel) project.

    Shea S; IDEATel Consortium.

    Trans Am Clin Climatol Assoc. 2007;118:289-304.PMID: 18528511 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    18.

    The Indiana Chronic Disease Management Program's impact on medicaid claims: a longitudinal, statewide evaluation.

    Katz BP, Holmes AM, Stump TE, Downs SM, Zillich AJ, Ackermann RT, Inui TS.

    Med Care. 2009 Feb;47(2):154-60.PMID: 19169115 [PubMed - indexed for MEDLINE]Related articles

    19.
    20.

    The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.

    Fera T, Bluml BM, Ellis WM, Schaller CW, Garrett DG.

    J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):181-90.PMID: 18359731 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data